Results of Past Studies

Chemo - Laboratories Leon Farma S.A - Birth Control CF

CHEMO/Exeltis is very pleased to announce FDA's approval of the Slynd (drosperinone) for prescription use in the United States.

AbbVie - Endometriosis

AbbVie receives U.S. FDA Approval of ORILISSA (elagolix) for the Management of Monderate to Severe Pain Associated with Endometriosis.

Endoceutics- Vaginal Atrophy

Endoceutics® Receives Health Canada Approval for Intraraosa®. The first innovative drug for the treatment of vulvovaginal atrophy with prasterone.

Regeneron

Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

Enroll Today!
Please fill out the form below if you are interested in volunteering
for any of our current or future studies